Boston Children's Hospital

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

Retrieved on: 
Thursday, March 28, 2024
Internal medicine, Boston Children's Hospital, Harvard Medical School, Swedish Orphan Biovitrum, Massachusetts General Hospital, Genzyme, Patient, SAN, Inflammation, Senior, Pediatrics, KIT, Hospital, Medicine, Management

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the appointment of Geoff McDonough, M.D., to its Board of Directors.

Key Points: 
  • SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the appointment of Geoff McDonough, M.D., to its Board of Directors.
  • Prior to this role, he served as the President and Chief Executive Officer of Swedish Orphan Biovitrum AB (Sobi) from 2011 to 2017.
  • at Harvard Medical School and completed residency training in internal medicine and pediatrics at Massachusetts General Hospital and Boston Children's Hospital.
  • “I am excited to join the exceptional team at Third Harmonic Bio in working to expand the treatment landscape for mast cell disorders.”

Boston Children’s Hospital and NRG Energy celebrate $1 million milestone, thanks to the Choose to Give program

Retrieved on: 
Thursday, March 28, 2024
Hospitals, Other Energy, Utilities, Philanthropy, Energy, Health, Fund Raising, General Health, Other Philanthropy, Electricity, Boston Children's Hospital, Government, Learning, Partnership, NRG, Hospital trust, Research, Rombach, Hospital, NRG Energy, Multimedia, Corporate development, Policy, Health insurance

NRG Energy, one of the leading suppliers of energy and home services in Massachusetts, today celebrated surpassing $1 million in contributions to Boston Children’s Hospital from its charitable program, Choose to Give .

Key Points: 
  • NRG Energy, one of the leading suppliers of energy and home services in Massachusetts, today celebrated surpassing $1 million in contributions to Boston Children’s Hospital from its charitable program, Choose to Give .
  • “We’re delighted to recognize NRG’s generous support,” said Michael Bornhorst, Vice President, Corporate Development, Leadership Giving & Special Events at Boston Children’s Hospital Trust.
  • “Our longstanding partnership with Boston Children’s Hospital is extremely important to us at NRG,” said Mike Rombach, Vice President and General Manager of NRG Home.
  • Customers interested in learning more about the NRG electricity plan benefiting Boston Children’s Hospital, or to enroll can visit picknrg.com/bch .

Rady Children's Appoints Praveen Raju, MD, PhD, as the Nathan Gordon Chair and Medical Director of Neuro-Oncology Program

Retrieved on: 
Tuesday, April 2, 2024
Research, Diagnosis, Boston Children's Hospital, Brain, Health, Growth, Neurology, MSTP, Memory, Genetics, SAN, Patient, UC, Cancer, Medulloblastoma, Child, University, Neurosurgery, Doctor of Philosophy, Neuro, MD, Molecular biology, NIH, Laboratory, Pediatric neurosurgery, Neoplasm, Infant, Nathan Gordon, Hospital, Spinal cord, Pediatrics, Neuro-Oncology (journal), Medical director, Genetic distance, Nursing

At Rady Children's, Dr. Raju has also been named the Nathan Gordon Chair in Neuro-Oncology, established in 2021 to honor the memory of Nathan Gordon, who was diagnosed with a rare tumor in his spinal cord when he was just 15 months old.

Key Points: 
  • At Rady Children's, Dr. Raju has also been named the Nathan Gordon Chair in Neuro-Oncology, established in 2021 to honor the memory of Nathan Gordon, who was diagnosed with a rare tumor in his spinal cord when he was just 15 months old.
  • As part of Rady Children's nationally recognized care team, Dr. Raju will spearhead the growth of the Neuro-Oncology Program and advance research efforts on pediatric brain and spinal tumors.
  • By incorporating subspecialty expertise, Dr. Raju aims to address different forms of pediatric brain and spinal tumors.
  • By incorporating subspecialty expertise into the Neuro-Oncology Program, Dr. Raju aims to address the different forms and distinct molecular subtypes of pediatric brain and spinal tumors.

Boston Children's Hospital Named Client of the Year for Creating World-class Central Sterile Processing Department

Retrieved on: 
Tuesday, April 2, 2024
Boston Children's Hospital, Culture, HSPA, Education, SPD, Supply chain management, Partnership, Sterilization, Patient, Senior, Supply, Hospital, Quality assurance, Patient safety, Customer service, Boston, Nursing

CHICAGO, April 2, 2024 /PRNewswire/ -- Boston Children's Hospital has been honored with the prestigious "Client of the Year" award by Surgical Directions, recognizing the hospital's exceptional achievements in revolutionizing its Central Sterile Processing Department (SPD).

Key Points: 
  • CHICAGO, April 2, 2024 /PRNewswire/ -- Boston Children's Hospital has been honored with the prestigious "Client of the Year" award by Surgical Directions, recognizing the hospital's exceptional achievements in revolutionizing its Central Sterile Processing Department (SPD).
  • Teamwork: Boston Children's fostered a culture of collaboration and teamwork, emphasizing leadership presence on the floor, department huddles, and multidisciplinary collaborative reviews.
  • Strategic Outlook: Boston Children's strategic plan focuses on accountability, responsibility, and partnerships, with initiatives aimed at continuous improvement and cementing its position as a world-class Sterile Processing Department.
  • Furthermore, through their partnership, Boston Children's was named Healthcare Sterile Processing Association's (HSPA) Quality Award Winner in February.

Harbour BioMed Reports Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 28, 2024
GMG, Patient, Stock exchange, Quality of life, Protein engineering, Bank statement, Investment, Therapy, Research, HBM, Biotechnology, Partnership, ITM, Motherboard, Trial of the century, Neonatal Fc receptor, Safety, PD-L1, ADC, Hepatocellular carcinoma, Boston Children's Hospital, U.S. FDA, Longevity, MSLN, Harbor, Hospital, NK, Engineering, NMPA, AstraZeneca, Biology, Ecosystem, Idea, Pharmaceutical industry

We recorded a significant increase in our revenue, demonstrating the Company's excellent global business development capabilities," said Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.

Key Points: 
  • We recorded a significant increase in our revenue, demonstrating the Company's excellent global business development capabilities," said Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.
  • Harbour BioMed recorded the profit of US$22.8 million for the year ended 31 December 2023.
  • This is the first time that the Company has recorded a net profit on its annual financial statements.
  • Looking to the future, Harbour BioMed will keep driving business growth and accomplishing its mission through two key pillars, Harbour Therapeutics and Nona Biosciences.

Simmons University Institute for Inclusive Leadership Announces Helen G. Drinan Visionary Leader Award winner, Thasunda Brown Duckett

Retrieved on: 
Thursday, March 14, 2024
PepsiCo, Boston Children's Hospital, Gender, Conference, TIAA, Entrepreneurship, Health, Simmons University, JPMorgan Chase, Education, Care.com, Woman, Former, Hospital, Workforce, Management

BOSTON, March 14, 2024 /PRNewswire/ -- The Simmons University Institute for Inclusive Leadership , a global authority on leadership, gender equity, and inclusion, is pleased to announce the 2024 recipient of the Helen G. Drinan Visionary Leader Award winner, Thasunda Brown Duckett.

Key Points: 
  • BOSTON, March 14, 2024 /PRNewswire/ -- The Simmons University Institute for Inclusive Leadership , a global authority on leadership, gender equity, and inclusion, is pleased to announce the 2024 recipient of the Helen G. Drinan Visionary Leader Award winner, Thasunda Brown Duckett.
  • The Visionary Leader Award, given in honor of Simmons University's eighth president, Helen G. Drinan is awarded annually to a leader who embodies the Institute's mission to manifest equity in leadership and create a more inclusive workforce.
  • "I am delighted that the Institute for Inclusive Leadership is honoring a leader who has excelled in the financial services industry.
  • Having spent twenty years in banking, I know firsthand how challenging it is to break into executive leadership," said Helen G. Drinan, President Emerita, Simmons University.

Acclaimed Clinical Geneticist Dr. Bruce Korf Honored with 2024 David L. Rimoin Lifetime Achievement Award in Medical Genetics from the ACMG Foundation for Genetic and Genomic Medicine

Retrieved on: 
Wednesday, March 13, 2024
Department of Defence, Friends, Patient, Medical genetics, Travel, Child, Neurofibromatosis, Practice, UAB, Gene expression, Dean (education), Education, Rockefeller University, Seed, NF, NIH, American College, Pediatrics, Person, Karyotype, MD–PhD, Boston Children's Hospital, Principle, Birmingham School of Law, Neurology, FACOG, Genetics, Cornell University, American Journal, Research, Hospital, University, Human genetics, Student, Publication, DRS, ACMG, Book, Genetic distance, DSM-IV codes, Diagnosis, FACMG, Empathy, Montefiore Medical Center, Distinguishing, Mouse, Hope, Doctor of Philosophy, Life, Genetic, Bangladesh Technical Education Board, Physician, Nursing

BETHESDA, Md., March 13, 2024 /PRNewswire/ -- Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.

Key Points: 
  • BETHESDA, Md., March 13, 2024 /PRNewswire/ -- Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.
  • Dr. Korf is an authentic, kind and ethical human being whose life and career in medical genetics are unparalleled."
  • "Dr. Korf's extraordinary accomplishments in clinical genetics, neurofibromatosis, and genomics, as well as his dedication to education make him a well deserving winner of the David Rimoin Lifetime Achievement Award.
  • Before he died, David appreciated the opportunity to work with Bruce first-hand in the editing of Principles and Practice of Medical Genetics as well as on numerous committees for the ACMG.

Job Research Foundation Announces 2024 Grant Recipient

Retrieved on: 
Tuesday, March 12, 2024
Boston Children's Hospital, University of Pennsylvania, Disease, University of Freiburg, Associate, Patient, Hyperimmunoglobulin E syndrome, Research, Gene editing, Rockefeller University, Columbia University, University, Hospital, Aarhus University, Multimedia, University of Newcastle, Barber–Say syndrome, Pharmaceutical industry

NEW YORK, March 12, 2024 /PRNewswire/ -- The Job Research Foundation was established to underwrite research into Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), a rare multisystem immunodeficiency disorder.

Key Points: 
  • NEW YORK, March 12, 2024 /PRNewswire/ -- The Job Research Foundation was established to underwrite research into Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), a rare multisystem immunodeficiency disorder.
  • This year's recipient, Dr. Rasmus O. Bak, Associate Professor at Aarhus University in Denmark, will receive a grant totaling $200,000.
  • Since 2019 the Job Research Foundation has funded a total of 15 scientific research projects.
  • The Job Research Foundation will start accepting the next round of grant applications in July 2024.

New consortium of healthcare leaders announces formation of Trustworthy & Responsible AI Network (TRAIN), making safe and fair AI accessible to every healthcare organization

Retrieved on: 
Monday, March 11, 2024
Informatics, Algorithm, Responsibility, Information technology, Health, Biomedical Research, Patient, Cleveland Clinic, Approximation error, Artificial intelligence in healthcare, Microsoft, Public, AdventHealth, Mass General Brigham, Coalition, Science, Policy, Safety, Boston Children's Hospital, VUMC, Organization, Bias, Trust (social science), Research, AI, University, Nouvelle AI, MPH, Vanderbilt University Medical Center, Hospital, Sharp HealthCare, Internal medicine, Health informatics, Conference, Public health, Cardiology, Caregiver, MedStar Health, CHAI, HIMSS, Mount Sinai Health System, Medical device

New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.

Key Points: 
  • New AI capabilities have the potential to transform the healthcare industry by enabling better care outcomes, improving efficiency and productivity, and reducing costs.
  • Enabling registration of AI used for clinical care or clinical operations through a secure online portal.
  • "By working together, TRAIN members aim to establish best practices for operationalizing responsible AI, helping improve patient outcomes and safety while fostering trust in healthcare AI."
  • "We are excited to join our TRAIN partners in the journey to accelerate AI innovation in an ethical, responsible and safe way."

American Brain Tumor Association Announces New Board of Directors Officers and Members

Retrieved on: 
Tuesday, February 27, 2024
International law, Prostate cancer, Candel, Cancer, Hospital, IPO, Doctor of Philosophy, Partner, Therapy, Texas Children's Hospital, Patient, ABTA, Baylor College of Medicine, American Brain Tumor Association, Harvard Medical School, Brain, Research, Boston Children's Hospital

CHICAGO, Feb. 27, 2024 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of officers and new members to serve as the Board of Directors.

Key Points: 
  • CHICAGO, Feb. 27, 2024 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of officers and new members to serve as the Board of Directors.
  • They will advance the ABTA mission under the leadership of Ram Subramanian, Board Chair, and Ralph DeVitto, President and CEO.
  • "Over the past year, the American Brain Tumor Association has experienced tremendous growth, demonstrating the impact of our board's vision and commitment," DeVitto said.
  • The 2024 ABTA Board of Directors Officers and Members: